Cargando…

The effects of dydrogesterone treatment on first-trimester aneuploidy screening markers and nuchal translucency in women with threatened miscarriage

OBJECTIVE: To evaluate the effects of dydrogesterone treatment on first-trimester aneuploidy screening markers and nuchal translucency (NT) in women with threatened miscarriage. MATERIALS AND METHODS: This study is an prospective case-control study. One hundred seven pregnant women who applied for t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yıldız, Elif, Timur, Burcu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2023
Materias:	Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013081/ https://www.ncbi.nlm.nih.gov/pubmed/36908009 http://dx.doi.org/10.4274/tjod.galenos.2023.97493

Ejemplares similares

The effect of progesterone use in the first trimester on fetal nuchal translucency
por: Namlı Kalem, Müberra, et al.
Publicado: (2018)

Evaluation of Nuchal Translucency Measurement in First Trimester Pregnancy
por: Barati, Mojgan, et al.
Publicado: (2011)

Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?
por: Bardi, Francesca, et al.
Publicado: (2019)

A systematic review of dydrogesterone for the treatment of threatened miscarriage
por: Carp, Howard
Publicado: (2012)

Is There a Relationship Between First-Trimester Aneuploidy Screening Serum Biomarker Values and Nuchal Translucency Measurements and the Development of Retinopathy of Prematurity (ROP) in Premature Infants?
por: Küçük, Mehmet Fatih, et al.
Publicado: (2023)

Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?
por: Kalem, Ziya, et al.
Publicado: (2019)

Different Cutoff Values for Increased Nuchal Translucency in First-Trimester Screening to Predict Fetal Chromosomal Abnormalities
por: Su, Linjuan, et al.
Publicado: (2021)

Chromosomally and Anatomically Normal Fetuses With Increased First Trimester Nuchal Translucency Conceived by ICSI
por: Niknejadi, Maryam, et al.
Publicado: (2015)

A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial
por: Chan, Diana Man Ka, et al.
Publicado: (2016)

Recurrent increased nuchal translucency: a first trimester presentation of familial 13p satellite deletion
por: Uzun, I, et al.
Publicado: (2016)

Maternal Parvovirus B19 Infection Causing First-Trimester Increased Nuchal Translucency and Fetal Hydrops
por: Grubman, Olivia, et al.
Publicado: (2019)

The Effect of Vanishing Twin on First- and Second-Trimester Maternal Serum Markers and Nuchal Translucency: A Multicenter Prospective Cohort Study
por: Lee, Se Jin, et al.
Publicado: (2023)

Distribution of nuchal translucency in antenatal screening for Down's syndrome
por: Bestwick, J P, et al.
Publicado: (2010)

Distribution of nuchal translucency in antenatal screening for Down's syndrome
Publicado: (2010)

Increased nuchal translucency and pregnancy outcomes: experience of Başkent University Ankara Hospital
por: Şahin Uysal, Nihal, et al.
Publicado: (2019)

Increased Nuchal Translucency and Pregnancy Outcome
por: Tahmasebpour, A, et al.
Publicado: (2012)

Fetal nuchal translucency scan in Nigeria
por: Oloyede, Olufemi Adebari, et al.
Publicado: (2014)

Normal reference range of fetal nuchal translucency thickness in pregnant women in the first trimester, one center study
por: Sharifzadeh, Marzeie, et al.
Publicado: (2015)

Isolated Increased Nuchal Translucency in First Trimester Ultrasound Scan: Diagnostic Yield of Prenatal Microarray and Outcome of Pregnancy
por: Stuurman, Kyra E., et al.
Publicado: (2021)

The value of screening for major fetal abnormalities during the nuchal translucency examination
por: Wye, Deborah, et al.
Publicado: (2015)

Development and Validation of a Deep Learning Model to Screen for Trisomy 21 During the First Trimester From Nuchal Ultrasonographic Images
por: Zhang, Liwen, et al.
Publicado: (2022)

Ultrasound and echocardiographic findings obtained in the second and third trimesters of gestation in fetuses with normal karyotype and increased nuchal translucency
por: Moczulska, Hanna, et al.
Publicado: (2013)

Simplified protocol of nuchal translucency measurement: Is it still effective?
por: Kim, Sun Min, et al.
Publicado: (2013)

A prospective study to assess the clinical impact of interobserver reliability of sonographic measurements of fetal nuchal translucency and crown-rump length on combined first-trimester screening
por: Aksoy, Huseyin, et al.
Publicado: (2015)

First trimester diagnosis and screening for fetal aneuploidy
por: Driscoll, Deborah A., et al.
Publicado: (2008)

Efficacy and safety of Gushen Antai Pills combined with dydrogesterone in the treatment of threatened miscarriage: a systematic review and meta-analysis
por: Chen, Kai, et al.
Publicado: (2023)

The Distribution of Fetal Nuchal Translucency Thickness in Normal Korean Fetuses
por: Chung, Jin-Hoon, et al.
Publicado: (2004)

Detection of Fetal Abnormalities Based on Three Dimensional Nuchal Translucency
por: Lai, Khin Wee, et al.
Publicado: (2013)

Clinical significance of nuchal translucency measurement in routine prenatal examination
por: Zhao, Xin-Rong, et al.
Publicado: (2021)

Ultrasonography of the nuchal translucency of healthy and abnormal English Bulldog fetuses
por: Pavan, Letícia, et al.
Publicado: (2021)

Effect of Exogenous Progesterone on Fetal Nuchal Translucency: An Observational Study
por: Bagde, Nilajkumar D, et al.
Publicado: (2022)

Pregnancy outcomes of normal karyotype fetuses with increased nuchal translucency
por: Niroomanesh, Shirin, et al.
Publicado: (2023)

Prenatal whole‐exome sequencing in fetuses with increased nuchal translucency
por: Cao, Chunge, et al.
Publicado: (2023)

First Trimester Aneuploidy Screening Markers in Women with Pre-Gestational Diabetes Mellitus
por: Gurram, Padmalatha, et al.
Publicado: (2014)

Analysis of Quality of Nuchal Translucency Measurements: Its Role in Prenatal Diagnosis
por: Gabriel, Carmen Comas, et al.
Publicado: (2011)

Prenatal Diagnosis of Fetuses With Increased Nuchal Translucency by Genome Sequencing Analysis
por: Choy, Kwong Wai, et al.
Publicado: (2019)

Chromosomal Microarray Analysis versus Karyotyping in Fetuses with Increased Nuchal Translucency
por: Cicatiello, Rita, et al.
Publicado: (2019)

Analysis of copy number variation by sequencing in fetuses with nuchal translucency thickening
por: Lan, Liubing, et al.
Publicado: (2020)

Prenatal diagnosis of Pfeiffer syndrome type 2 with increased nuchal translucency
por: Hu, Zhi‐yang, et al.
Publicado: (2021)

Increased nuchal translucency before 11 weeks of gestation: Reason for referral?
por: Lugthart, Malou A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tbs45ftii4lpk1ur7gk4s99t6l